News
Less than a quarter of adults and around 13% of children have gotten a COVID-19 vaccination this past season, CDC data shows, ...
The US Centers and Disease Control and Prevention is considering recommending annual Covid-19 shots to those who are older or ...
Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...
The CDC's vaccine committee will convene for a two-day meeting this week to consider recommendations on vaccines, including the COVID-19 vaccine for 2025-2026.
Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...
In the first meeting of the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices (ACIP) ...
Officials at the Department of Health and Human Services have struggled to find records belonging to Dr. Tom Shimabukuro, the director of the CDC’s Immunization Safety Office.
As in previous studies, the SHIELD study found health care workers who received the Novavax vaccine reported significantly ...
Five years ago, volunteers rolled up their sleeves in the first clinical trial of a vaccine against COVID-19, as the new ...
Novavax (NVAX) announced preliminary results from the SHIELD-Utah study that showed Novavax’s COVID-19 Vaccine, Adjuvanted 2024-2025 Formula ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results